SMAD7 and breast carcinoma: Moreover, we confirmed the requirement of an active TGF‐β signalling in breast cancer cells by showing that CAF‐induced MCF7 migration is impaired in SMAD7 overexpressing cancer cells (Figure S8a) and by SB431542 treatment (Figure S8b).